A total of 1 analyst ratings have been received for Sotera Health, with the consensus rating being Outperform. The average one-year price target stands at $13.0, suggesting a potential 17.54% upside.

AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their ...

Advanced Sterilization Products (ASP), a global leader in infection prevention and sterilization solutions, is announcing the launch of the BIOTRACE™ Instant Read Steam System, the fastest FDA-cleared ...

Following years of heightened concern about the dangers of exposure to ethylene oxide (EtO), increased regulatory oversight, and a steady hum ...

This article argues that in organizations of any size and complexity, it is impossible to manage for results in the long or short run without a well-developed capacity for strategic management, ...